Pulse pressure and michigan neuropathy screening instrument are independently associated with asymptomatic peripheral arterial disease among type 2 diabetes community residents: A community-based screening program in Taiwan

Biomedical Journal

Volumn 36, Issue 6, 2013, Pages 282-288

  Fan, Li Chi ^a   Chen, Mei Yen ^b   Huang, Wei Chao ^c   Ho, Cheng ^a   Chen, Pao Yin ^a   Huang, Jui Chu ^a   Weng, Hsu Huei ^d   Peng, Yun Shing ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Asymptomatic; diabetes mellitus; Michigan Neuropathy Screening Instrument; peripheral arterial disease; pulse pressure

Indexed keywords

ADULT; AGE; AGED; ANKLE BRACHIAL INDEX; ARTICLE; ASYMPTOMATIC DISEASE; CEREBROVASCULAR ACCIDENT; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MICHIGAN NEUROPATHY SCREENING INSTRUMENT SCORE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PULSE PRESSURE; RISK FACTOR; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; TAIWAN; VERY ELDERLY;

AGED; ANKLE BRACHIAL INDEX; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; RISK ASSESSMENT; TAIWAN;

EID: 84891858429     PISSN: 23194170     EISSN: None     Source Type: Journal    
DOI: 10.4103/2319-4170.113371     Document Type: Article

References (33)

1. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003;26:3333-41.
2. McDermott MM, Mehta S, Greenland P. Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease. Arch Intern Med 1999;159:387-92.
3. Barretto S, Ballman KV, Rooke TW, Kullo IJ. Early-onset peripheral arterial occlusive disease: Clinical features and determinants of disease severity and location. Vasc Med 2003;8:95-100.
4. Adler AI, Boyko EJ, Ahroni JH, Smith DG. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care 1999;22:1029-35.
5. Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: A comparison of severity and outcome. Diabetes Care 2001;24:1433-7.
6. Mohler ER 3rd, Treat-Jacobson D, Reilly MP, Cunningham KE, Miani M, Criqui MH, et al. Utility and barriers to performance of the ankle-brachial index in primary care practice. Vasc Med 2004;9:253-60.
7. Fowkes FG, Housley E, Macintyre CC, Prescott RJ, Ruckley CV. Variability of ankle and brachial systolic pressures in the measurement of atherosclerotic peripheral arterial disease. J Epidemiol Community Health 1988;42:128-33.
8. van Langen H, van Gurp J, Rubbens L. Interobserver variability of ankle-brachial index measurements at rest and post exercise in patients with intermittent claudication. Vasc Med 2009;14:221-6.
9. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (Updating the 2005 Guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011;124:2020-45.
10. Eason SL, Petersen NJ, Suarez-Almazor M, Davis B, Collins TC. Diabetes mellitus, smoking, and the risk for asymptomatic peripheral arterial disease: Whom should we screen? J Am Board Fam Pract 2005;18:355-61.
11. Aronow WS, Ahmed MI, Ekundayo OJ, Allman RM, Ahmed A. A propensity-matched study of the association of peripheral arterial disease with cardiovascular outcomes in community-dwelling older adults. Am J Cardiol 2009;103:130-5.
12. Khedara A, Kawai Y, Kayashita J, Kato N. Feeding rats the nitric oxide synthase inhibitor, L-N (omega) nitroarginine, elevates serum triglyceride and cholesterol and lowers hepatic fatty acid oxidation. J Nutr 1996;126:2563-7.
13. Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg 2006;108:477-81.
14. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: A meta-analysis. JAMA 2008;300:197-208.
15. Lange S, Diehm C, Darius H, Haberl R, Allenberg JR, Pittrow D, et al. High prevalence of peripheral arterial disease but low antiplatelet treatment rates in elderly primary care patients with diabetes. Diabetes Care 2003;26:3357-8.
16. Rabia K, Khoo EM. Prevalence of peripheral arterial disease in patients with diabetes mellitus in a primary care setting. Med J Malaysia 2007;62:130-3.
17. Maeda Y, Inoguchi T, Tsubouchi H, Sawada F, Sasaki S, Fujii M, et al. High prevalence of peripheral arterial disease diagnosed by low ankle-brachial index in Japanese patients with diabetes: The Kyushu prevention study for atherosclerosis. Diabetes Res Clin Pract 2008;82:378-82.
18. Rhee SY, Guan H, Liu ZM, Cheng SW, Waspadji S, Palmes P, et al. Multi-country study on the prevalence and clinical features of peripheral arterial disease in Asian type 2 diabetes patients at high risk of atherosclerosis. Diabetes Res Clin Pract 2007;76:82-92.
19. Tseng CH. Prevalence and risk factors of peripheral arterial obstructive disease in Taiwanese type 2 diabetic patients. Angiology 2003;54:331-8.
20. Hirsch AT, Hartman L, Town RJ, Virnig BA. National health care costs of peripheral arterial disease in the Medicare population. Vasc Med 2008;13:209-15.
21. Franklin SS. Cardiovascular risks related to increased diastolic, systolic and pulse pressure. An epidemiologists point of view. Pathol Biol (Paris) 1999;47:594-603.
22. Knudsen ST, Poulsen PL, Hansen KW, Ebbehoj E, Bek T, Mogensen CE. Pulse pressure and diurnal blood pressure variation: Association with micro-and macrovascular complications in type 2 diabetes. Am J Hypertens 2002;15:244-50.
23. Zoppini G, Verlato G, Zamboni C, Venturi C, Gennaro N, Biasi V, et al. Pulse pressure and mortality from cerebrovascular diseases in type 2 diabetic patients: The Verona Diabetes Study. Cerebrovasc Dis 2007;23:20-6.
24. Zoppini G, Verlato G, Targher G, Bonora E, Trombetta M, Muggeo M. Variability of body weight, pulse pressure and glycaemia strongly predict total mortality in elderly type 2 diabetic patients. The verona diabetes study. Diabetes Metab Res Rev 2008;24:624-8.
25. Schram MT, Kostense PJ, Van Dijk RA, Dekker JM, Nijpels G, Bouter LM, et al. Diabetes, pulse pressure and cardiovascular mortality: The hoorn study. J Hypertens 2002;20:1743-51.
26. Monami M, Vivarelli M, Desideri CM, Colombi C, Marchionni N, Mannucci E. Pulse pressure and prediction of incident foot ulcers in type 2 diabetes. Diabetes Care 2009;32:897-9.
27. Tseng CH. Pulse pressure as a risk factor for peripheral vascular disease in type 2 diabetic patients. Clin Exp Hypertens 2003;25:475-85.
28. Halon DA, Dobrecky-Mery I, Gaspar T, Azencot M, Yaniv N, Peled N, et al. Pulse pressure and coronary atherosclerosis in asymptomatic type 2 diabetes mellitus: A 64 channel cardiac computed tomography analysis. Int J Cardiol 2010;143:63-71.
29. Bax G, Fagherazzi C, Piarulli F, Nicolucci A, Fedele D. Reproducibility of michigan neuropathy screening instrument (MNSI). A comparison with tests using the vibratory and thermal perception thresholds. Diabetes Care 1996;19:904-5.
30. Meves SH, Diehm C, Berger K, Pittrow D, Trampisch HJ, Burghaus I, et al. Peripheral arterial disease as an independent predictor for excess stroke morbidity and mortality in primary-care patients: 5-year results of the getABI study. Cerebrovasc Dis 2010;29:546-54.
31. Sen S, Lynch DR Jr., Kaltsas E, Simmons J, Tan WA, Kim J, et al. Association of asymptomatic peripheral arterial disease with vascular events in patients with stroke or transient ischemic attack. Stroke 2009;40:3472-7.
32. Topakian R, Nanz S, Rohrbacher B, Koppensteiner R, Aichner FT. High prevalence of peripheral arterial disease in patients with acute ischaemic stroke. Cerebrovasc Dis 2010;29:248-54.
33. Tseng CH. An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Angiology 2002;53:529-37.